Development of antimycobacterial tetrahydrothieno [2, 3-c] pyridine-3-carboxamides and hexahydrocycloocta [b] thiophene-3-carboxamides: Molecular modification …
R Nallangi, G Samala, JP Sridevi, P Yogeeswari…
文献索引:Nallangi, Radhika; Samala, Ganesh; Sridevi, Jonnalagadda Padma; Yogeeswari, Perumal; Sriram, Dharmarajan European Journal of Medicinal Chemistry, 2014 , vol. 76, p. 110 - 117
Abstract Twenty derivatives of 2, 6-disubstituted 4, 5, 6, 7-tetrahydrothieno [2, 3-c] pyridine-3- carboxamide and ten of 2-substituted 4, 5, 6, 7, 8, 9-hexahydrocycloocta [b] thiophene-3- carboxamide were synthesized by molecular modification of a known antimycobacterial molecule. Compounds were evaluated in vitro against Mycobacterium tuberculosis (MTB), and cytotoxicity against RAW 264.7 cell line. Among the compounds, 2-(4- ...
[Masaoka, Takashi; Chung, Suhman; Caboni, Pierluigi; Rausch, Jason W.; Wilson, Jennifer A.; Taskent-Sezgin, Humeyra; Beutler, John A.; Tocco, Graziella; Le Grice, Stuart F. J. Journal of Medicinal Chemistry, 2013 , vol. 56, # 13 p. 5436 - 5445]
[Aurelio, Luigi; Christopoulos, Arthur; Flynn, Bernard L.; Scammells, Peter J.; Sexton, Patrick M.; Valant, Celine Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 12 p. 3704 - 3707]